Overview

The Therapeutic Effects of Topiramate and Metformin on Second Generation Antipsychotics-induced Obesity

Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary aim of the study is to investigate the efficacy of metformin and topiramate on second-generation antipsychotic-induced obesity. The secondary domain we look at is the adverse effects of both drugs. The investigators hypothesize that metformin and topiramate are effective in treating obesity induced by second-generation antipsychotics.
Phase:
N/A
Details
Lead Sponsor:
Beitou Armed Forces Hospital, Taipei, Taiwan
Treatments:
Antipsychotic Agents
Metformin
Topiramate